Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunoprevention of Human Papillomavirus–Associated Malignancies
Joshua W. Wang, C.‐F. Hung, Warner K. Huh, et al.
Cancer Prevention Research (2014) Vol. 8, Iss. 2, pp. 95-104
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth, Kathrin U. Jansen
npj Vaccines (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 608
Tumor‐infiltrating lymphocytes for the treatment of metastatic cancer
Marnix H. Geukes Foppen, Marco Donia, Inge Marie Svane, et al.
Molecular Oncology (2015) Vol. 9, Iss. 10, pp. 1918-1935
Open Access | Times Cited: 115
A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches
Manica Negahdaripour, Mahboobeh Eslami, Navid Nezafat, et al.
Infection Genetics and Evolution (2017) Vol. 54, pp. 402-416
Closed Access | Times Cited: 71
Multi-Strain Human Papillomavirus (HPV) Vaccine Innovation via Computational Study: A Mini Review
Viol Dhea Kharisma, Arif Nur Muhammad Ansori, Vikash Jakhmola, et al.
Research Journal of Pharmacy and Technology (2022), pp. 3802-3807
Closed Access | Times Cited: 28
Human papillomavirus and gastrointestinal cancer: A review
Dania Bucchi, Fabrizio Stracci, N. Buonora, et al.
World Journal of Gastroenterology (2016) Vol. 22, Iss. 33, pp. 7415-7415
Open Access | Times Cited: 60
Tumour virus vaccines: hepatitis B virus and human papillomavirus
Margaret Stanley
Philosophical Transactions of the Royal Society B Biological Sciences (2017) Vol. 372, Iss. 1732, pp. 20160268-20160268
Open Access | Times Cited: 60
Immunologic Control of Mus musculus Papillomavirus Type 1
Joshua W. Wang, Rosie Jiang, Shiwen Peng, et al.
PLoS Pathogens (2015) Vol. 11, Iss. 10, pp. e1005243-e1005243
Open Access | Times Cited: 50
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded
Sogand Amiri, Shiva Rasekh, Seyed Mohammad Iman Moezzi, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
Immunologic approaches to cancer prevention—current status, challenges, and future perspectives
Małgorzata Wójtowicz, Barbara K. Dunn, Asad Umar
Seminars in Oncology (2015) Vol. 43, Iss. 1, pp. 161-172
Closed Access | Times Cited: 38
Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach
Wai-Hong Wu, Tanwee Alkutkar, Balasubramanyan Karanam, et al.
Virology Journal (2015) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Less than 3 doses of the HPV vaccine – Review of efficacy against virological and disease end points
Partha Basu, Neerja Bhatla, Twalib Ngoma, et al.
Human Vaccines & Immunotherapeutics (2016) Vol. 12, Iss. 6, pp. 1394-1402
Open Access | Times Cited: 30
Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy
Nancy M. Cladel, Lynn R. Budgeon, Timothy K. Cooper, et al.
Journal of General Virology (2017) Vol. 98, Iss. 10, pp. 2520-2529
Open Access | Times Cited: 30
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Shiwen Peng, Jin Qiu, Andrew Yang, et al.
Cell & Bioscience (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 28
PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model
Shiwen Peng, Marietta Tan, Yen-Der Li, et al.
Cancer Immunology Immunotherapy (2020) Vol. 70, Iss. 4, pp. 1049-1062
Open Access | Times Cited: 26
Progress and prospects for L2-based human papillomavirus vaccines
Rosie Jiang, Christina Schellenbacher, Bryce Chackerian, et al.
Expert Review of Vaccines (2016) Vol. 15, Iss. 7, pp. 853-862
Open Access | Times Cited: 25
Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17–36 epitopes
Subhashini Jagu, Balusubramanyam Karanam, Joshua W. Wang, et al.
Vaccine (2015) Vol. 33, Iss. 42, pp. 5553-5563
Open Access | Times Cited: 21
A New Generation of Vaccines in the Age of Immunotherapy
Alfredo Addeo, Alex Friedlaender, Elisa Giovannetti, et al.
Current Oncology Reports (2021) Vol. 23, Iss. 12
Open Access | Times Cited: 15
Cancer Prevention: Lessons Learned and Future Directions
Barbara K. Dunn, Barnett S. Kramer
Trends in cancer (2016) Vol. 2, Iss. 12, pp. 713-722
Open Access | Times Cited: 15
Production and Preliminary In Vivo Evaluations of a Novel in silico-designed L2-based Potential HPV Vaccine
Manica Negahdaripour, Navid Nezafat, Reza Heidari, et al.
Current Pharmaceutical Biotechnology (2019) Vol. 21, Iss. 4, pp. 316-324
Closed Access | Times Cited: 14
Designing a therapeutic and prophylactic candidate vaccine against human papillomavirus through vaccinomics approaches
Ashkan Bagheri, Navid Nezafat, Mahboobeh Eslami, et al.
Infection Genetics and Evolution (2021) Vol. 95, pp. 105084-105084
Closed Access | Times Cited: 12
Primary Immunoprevention of Epithelial Ovarian Carcinoma by Vaccination against the Extracellular Domain of Anti-Müllerian Hormone Receptor II
Suparna Mazumder, Justin M. Johnson, Valerie Swank, et al.
Cancer Prevention Research (2017) Vol. 10, Iss. 11, pp. 612-624
Closed Access | Times Cited: 14
The evolution of lung adenocarcinoma precursors is associated with chromosomal instability and transition from innate to adaptive immune response/evasion
Jianjun Zhang, Xin Hu, Bo Zhu, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
The Association of Molecular Biomarkers in the Diagnosis of Cervical Pre-Cancer and Cancer and Risk Factors in Senegalese
Dominique Diouf, Gora Diop, Cheikh Fall, et al.
Asian Pacific Journal of Cancer Prevention (2020) Vol. 21, Iss. 11, pp. 3221-3227
Open Access | Times Cited: 10
Cancer Immunoprevention: A Case Report Raising the Possibility of “Immuno-interception”
Jessica G. Mancuso, William D. Foulkes, Michaël Pollak
Cancer Prevention Research (2020) Vol. 13, Iss. 4, pp. 351-356
Closed Access | Times Cited: 9
Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development
Sujita Khanal, Eric Daniel Ferraris, Maryam Zahin, et al.
Experimental and Molecular Pathology (2015) Vol. 99, Iss. 2, pp. 330-334
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top